In the present times of the prevailing COVID-19 outbreak, where workplaces are shut and there subsists a complete lockdown of humanity, a lot has happened in the domain of Direct taxes behind our back, ...

In March 2020, the Supreme Court took suo motu cognizance of the prejudicial impact of the Covid-19 restrictions on compliance with limitation periods, and this led to Suo Motu Writ Petition (Civil) No 3 of 2020.

All international travelers will be required to undergo a seven-day home quarantine period upon arrival in India 

With COVID-19 being declared a pandemic, various companies have found themselves facing challenges in complying with the Companies Act compliances due to disruptions in their operations.

The ongoing Covid-19 pandemic has caused substantial business disruption across all walks of life.

In order to support and help the Companies and Limited Liability Partnerships in India to focus on taking measures to address the COVID-19 threat and revive themselves from economic disruptions caused by it, ...

Industry has been struggling to cope with the ongoing economic slowdown despite fiscal, monetary and other support from the government. Reduced availability of capital has impacted ...

The Food Safety and Standards Authority of India (FSSAI) has issued a press release on April 20, 2021, wherein they have issued directions for facilitating food businesses during the prevailing...

Recently, Oravax Medical Inc., ("Oravax" has entered into a licensing agreement with Premas Biotech to make available for commercialization of Oravax's virus-like particle (VLP) vaccine technology.

India has introduced travel restrictions and advice to contain the spread of the coronavirus. This article provides details.

The government of India updated its COVID-19 guidelines on 3 September 2022. Based on these new guidelines, all travelers must...

The COVID-19 pandemic has wreaked havoc globally and has deeply penetrated in all our lives, thereby compelling us to bring about a paradigm...

In March 2020, the Supreme Court took suo motu cognizance of the impact of the Covid-19 restrictions on compliance with limitation periods, and this led to Suo Motu Writ Petition (Civil) No 3 of 2020.

The COVID-19 pandemic continues to pose several challenges to the domestic as well as international economic and commercial market.

Recently, Oravax Medical Inc., ("Oravax" has entered into a licensing agreement with Premas Biotech to make available for commercialisation Oravax's virus-like particle (VLP) vaccine technology.

The recent rise in the COVID-19 cases in India led the Hon'ble Supreme Court of India (Supreme Court) to pass another order dated 27 April 2021 (SC Order) in Suo Moto Writ Petition...

Citing inequitable access to vaccines, India and South Africa have called for waivers on provisions of the TRIPS Agreement for vaccines against COVID-19.

The government of India introduced new COVID-19 guidelines for all international travelers on 22 November 2022. All travelers entering the country must be fully vaccinated with an approved vaccine.

Industry has been struggling to cope with the ongoing economic slowdown despite fiscal, monetary and other support from the government.

Public private partnership (PPP) projects in the infrastructure sector have been among the worst affected during the covid-19 pandemic and the consequent lockdown...